期刊文献+

早期慢性肾脏病矿物质和骨代谢紊乱治疗的研究进展 被引量:8

下载PDF
导出
摘要 矿物质和骨代谢紊乱是慢性肾脏病的常见并发症之一,导致血磷、血钙的异常,不但引起骨关节的相关症状,而且增加患者心血管病的发病风险。指导患者合理饮食限磷,服用磷结合剂、骨化三醇等药物,可以实现对慢性肾脏病矿物质和骨代谢紊乱的早期预防和治疗,使患者得到长期的生存获益。
出处 《临床和实验医学杂志》 2013年第2期144-145,150,共3页 Journal of Clinical and Experimental Medicine
基金 北京市科技计划课题项目(Z121107001012138) 首都卫生发展科研专项(首发2011-2002-02)
  • 相关文献

参考文献29

  • 1Benini O, D'Alessandro C, Gianfaldoni D, et al. Extra - phosphate load from food additives in commonly eaten foods : a real and insidious danger for renal patients [ J ]. J Ren Nutr, 2011,21 (4) :303 - 308.
  • 2Cupisti A, D'Alessandro C. The impact of known and unknown dietary components to phosphorus intake[ J]. G Ital Nefrol, 2011,28 (3) :278 - 288.
  • 3Molony DA, Stephens BW. Derangements in phosphate metabolism in chronic kidney diseases/endstage renal disease: therapeutic considerations[J]. Adv Chronic Kidney Dis, 2011,18(2) :120 -131.
  • 4Lafage -Proust MH, Combe C, Barthe N, et al. Bone mass and dynamic parathyroid function according to bone histology in nondialyzed uremic patients after long -term protein and phosphorus restriction[J]. J Clin Endocrinol Metab, 1999,84 (2) :512 - 519.
  • 5Sherman RA, Mehta O. Dietary phosphorus restriction in dialysis patients: Potential impact of processed meat, poultry, and fish products as protein sources[J]. Am J Kidney Dis, 2009,54 (1) :18 -23.
  • 6Sherman RA, Mehta O. Phosphorus and potassium content of enhanced meat and poultry products : Implications for patients who receive dialysis [J]. Clin J Am Soc Nephrol, 2009,4(8) :1370 -1373.
  • 7Shinaberger CS, Greenland S, Kopple JD, et al. Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease [J] ? Am J Clin Nutr, 2008,88(6) : 1511 - 1518.
  • 8Russo D, Miranda I, Ruocco C, et al. The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer[J]. Kidney Int, 2007,72(10) :1255 -1261.
  • 9Isakova T, Gutierrez OM, Chang Y, et al. Phosphorus binders and survival on hemodialysis[ J]. J Am Soe Nephrol, 2009,20(2) :388 -396.
  • 10Kovesdy CP, Kuchmak O, Lu JL, et al. Outcomes associated with phosphorus binders in men with non - dialysis - dependent CKD [ J ]. Am J Kidney Dis, 2010,56(5) :842 -851.

同被引文献63

  • 1姜鸿,徐志宏,张凌,宋韩明,李文歌.慢性肾脏病3~5期透析前患者矿物质及骨代谢紊乱的调查分析[J].中国血液净化,2012,11(7):360-364. 被引量:43
  • 2Block GA,Klassen FS, Lazarus JM, et al. Mineral metabolism,mortality, and morbidity in maintenance hemodialysis [J]. JAm Soc Nephrol, 2004, 15 : 2208-2218.
  • 3Palmer SC, Hayen A, Macaskill P,et al. Serum levels ofphosphorus, parathyroid hormone, and calcium and risks ofdeath and cardiovascular disease in individuals with chronickidney disease: a systematic review and meta-analysis [J].JAMA, 2011,305: 1119-1127.
  • 4王梅.透析患者矿物质和骨代谢紊乱治疗现状调查分析.中华医学会肾脏病学分会2006年学术年会论文集.2006.
  • 5Kong X,Zhang L, Zhang L, et al. Mineral and bone disorderin Chinese dialysis patients : a multicenter study [ J ]. BMCNephrol, 2012, 13: 116.
  • 6K/DOQI. Clinical Practice Guidelines for Bone Metabolismand Disease in Chronic Kidney Disease [ J ]. Am J KidneyDis, 2003 , 42 ( 4 Suppl 3): Sl-201.
  • 7KDIGO. Clinical Practice Guideline for the Diagnosis, Evaluation,Prevention, and Treatment of Chronic Kidney Disease-Mineraland Bone Disorder ( CKD-MBD) [ j]. Kidney Int Suppl,2009, 113: Sl-130.
  • 8Xu J, Zhang YX, Yu XQ, et al. Lanthanum carbonate forthe treatment of hyperphosphatemia in CKD 5D: multicenter,double blind, randomized, controlled trial in China's Mainland[J]. BMC Nephrol, 2013, 14: 29.
  • 9Cannata-Andia JB, Fernandez-Martin JL, Locatelli F, et al.Use of phosphate- binding agents is associated with a lowerrisk of mortality [ j] . Kidney Int, 2013’ 84: 998-1008.
  • 10孙友芬. 浅谈降钙素在慢性肾脏病矿物质及骨代谢紊乱患者治疗中的应用效果评价[J]. 世界最新医学信息文摘,2014,14(34):186-187.

引证文献8

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部